SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Purple Biotech Reports Third Quarter 2026 Financial Results and Provides Business Update

IM1240 tri-specific antibody (capped-CD3x5T4xNKG2A): Investigational New Drug (IND) application subm

PPBT

Related stories